N4 Pharma (GB:N4P) has released an update.
N4 Pharma PLC, a specialist pharmaceutical company, reports the successful passing of all resolutions at its recent AGM, including the re-election of directors and the appointment of auditors. The company, known for developing the innovative Nuvec® delivery system for cancer treatments and vaccines, continues to focus on partnerships and licensing deals to progress its products towards the market with plans for future royalty streams.
For further insights into GB:N4P stock, check out TipRanks’ Stock Analysis page.
